Applied Cells
- Company typePrivate
- Founded2016
- HeadquartersSanta Clara, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Applied Cells firmographics
Firmographics- Name
- Applied Cells
- Legal name
- Applied Cells Inc.
- Website
- https://appliedcells.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Applied Cells industry classification
Industry- Product category
- Cell Separation and Cell Therapy Manufacturing Instruments
- NAICS
- Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Cell Therapy Manufacturing Platforms & Automation (closed systems, bioreactors, fill-finish) (HLAAABAG)
- akta.pro secondary industry
- Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables) (HLAAABAH)
Keywords
Where Applied Cells is headquartered
LocationHeadquarters
- HQ city
- Santa Clara
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Applied Cells business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- MARS Instruments: Sale of MARS Bar, MARS Bar Flex, MARS SP, and MARS CS instruments for cell separation and sample preparation applications.
- Reagent Kits: Sale of MARS Ingenuity, MARS MAG Line, and MARS MAG Premium Line reagent kits including RUO and GMP-grade beads for various cell isolation applications.
- Consumables: Recurring sales of sterile fluidics tubing sets, containment bags, and other single-use consumables for MARS instruments.
- GoFast CAR-T Kit: Complete end-to-end kit for rapid CAR-T manufacturing including consumables and off-the-shelf CD19 LVV for pre-clinical testing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | GoFast CAR-T Kit Early Access - Complete CAR-T manufacturing kit |
| Other | Multi-year contract | CellQuest Research Grant - Multiple Myeloma Research Support |
Go-to-market motion4 records
Distribution channels5 records
Marketing channels8 records
Applied Cells product offering
Product offeringCore offering
Applied Cells designs, manufactures, and sells the MARS platform — column-free immunomagnetic cell separation instruments (MARS Bar, MARS Bar Flex, MARS Atlas, MARS SP, MARS CS) together with associated reagent kits, sterile fluidics, and the GoFast CAR-T manufacturing workflow and kit — to support cell therapy development, diagnostics, and life-science research. The offering is sold primarily to pharmaceutical, biotech, and academic customers via direct sales, regional distributors, and early-access programs.
Product overview
Applied Cells offers the MARS® platform, a comprehensive cell separation and isolation system comprising multiple instruments (MARS® Bar, MARS® Bar Flex, MARS® Atlas, MARS® SP, MARS® CS) and three reagent lines (Ingenuity™, MAG Line, MAG Premium Line). The platform uses proprietary column-free immunomagnetic separation technology for automated, gentle cell isolation with high purity and recovery. Key offerings include GoFast™ CAR-T workflow/kit for rapid CAR-T manufacturing in under 72 hours targeting <$10K cost of goods. The portfolio serves cell therapy development, diagnostics, genomics sample preparation, and cancer research applications.
Differentiator
Problem solved
Functional benefit
Brands
- MARS: Platform technology family for cell separation including MARS Bar, MARS Bar Flex, MARS Atlas, MARS CS, and MARS SP instruments
- GoFast
- MARS Ingenuity
- MARS MAG Line
- MARS MAG Premium Line
- Ingenuity
Products and services
- MARS® Bar Instrument Automated, ISO 13485:2016-certified column-free immunomagnetic cell separation instrument for GMP-compatible positive and negative cell selection workflows in cell therapy development. Targeted at pharmaceutical, biotech, and academic cell therapy developers.
- MARS® Bar Flex Instrument Flexible research-grade column-free cell separation system that independently processes 1–3 samples at a time with high purity and recovery, aimed at academic and translational research labs.
- MARS® Atlas Instrument End-to-end automated, closed-system instrument for rapid CAR-T cell therapy manufacturing, executing isolation, transduction, and purification to produce CAR-T cells within 24–48 hours. Targeted at cell therapy developers scaling clinical and commercial manufacturing.
- MARS® SP (Sample Preparation) Instrument Acoustic-based label-free sample preparation instrument for gentle cell washing, debris removal, and cell concentration without centrifugation, suitable for genomics sample prep, flow cytometry pre-enrichment, and delicate cell types.
- MARS® CS (Cell Separation) Instrument Integrated cell separation system combining label-free acoustic sample preparation with immuno-magnetic selection, providing flexible assay optimization for researchers developing cell isolation protocols.
- GoFast™ CAR-T Manufacturing Workflow End-to-end CAR-T manufacturing workflow that compresses traditional 2–3 week timelines to under 72 hours while targeting a cost of goods under $10,000, designed for cell therapy developers readying for clinical and commercial production.
- GoFast™ CAR-T Kit All-in-one end-to-end kit for rapid CAR-T manufacturing under 72 hours, including complete consumables and off-the-shelf CD19 lentiviral vector, designed for use with the MARS Bar system in B+A/C+A cleanroom environments and targeting COGS below $10,000.
- MARS® Ingenuity™ Reagents Biodegradable immunomagnetic reagent kits using 50nm superparamagnetic nanobeads and 4.5μm microbeads, available in both RUO and GMP grades, supporting cell isolation workflows for cell therapy developers. Includes CD34, TCR α/β, and CD56 GMP-grade nanobeads.
- MARS® MAG Line Reagents Anti-PE Magnetic Nanobead-based reagent line enabling fast, no-wash, column-free isolation of PE-labeled white blood cell subpopulations such as T cells, B cells, monocytes, neutrophils, and rare cells for research and diagnostic use.
- MARS® MAG Premium Line Reagents Premium cell separation reagent kits co-developed with STEMCELL Technologies, providing high-purity kits for granulocytes, NK cells, plasma cells, and other cell types with protocols optimized for MARS instruments.
Quantifiable outcome
- GoFast workflow produces CAR-T cells in under 72 hours vs traditional 2-3 weeks
- +7 more outcomes
Companies that use Applied Cells
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
Applied Cells technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Applied Cells partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- SHENTEKcoreCollaboration to integrate fast QC release solutions with Applied Cells' GoFast CAR-T manufacturing workflow, enabling accelerated quality control testing for CAR-T cell therapy production.
- Immuneel TherapeuticscoreStrategic collaboration framework to jointly advance affordable CAR-T therapies, combining Applied Cells' manufacturing technology with Immuneel's expertise in cell therapy development.
- STEMCELL TechnologiescoreLaunched MARS MAG Premium Line of reagents in collaboration with STEMCELL Technologies, offering optimized kits for cell isolation including granulocytes, NK cells, and plasma cells with protocols designed for MARS instruments.
- GenScriptminorStrategic collaboration to deliver combined solutions for cell therapy development, integrating Applied Cells' MARS platform with GenScript's synthetic biology and cell therapy tools.
- S2 GenomicsminorCollaborative marketing agreement to provide a powerful tumor biology solution combining Applied Cells' MARS platform with S2 Genomics' tissue sample preparation technology.
- Masaryk University CREATIC Centre of ExcellenceminorMARS platform showcased at the opening of new CREATIC Centre of Excellence facilities at Masaryk University in Brno, supporting advanced cell therapy research in Central Europe.
- University of PennsylvaniaminorEvaluation agreement for new MARS platform technology at UPenn's cell therapy research facilities to assess performance for various cell isolation applications.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Applied Cells competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Applied Cells social profiles
Digital presenceApplied Cells compliance and trust
Trust signalCompliance6 records
Applied Cells financial estimates
Financial estimateRevenue estimate
Valuation estimate
Applied Cells leadership team
Management profileNumber of profiles
Profiles1 record
Applied Cells funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Applied Cells M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Applied Cells
What does Applied Cells do?
Applied Cells designs, manufactures, and sells the MARS platform — column-free immunomagnetic cell separation instruments (MARS Bar, MARS Bar Flex, MARS Atlas, MARS SP, MARS CS) together with associated reagent kits, sterile fluidics, and the GoFast CAR-T manufacturing workflow and kit — to support cell therapy development, diagnostics, and life-science research. The offering is sold primarily to pharmaceutical, biotech, and academic customers via direct sales, regional distributors, and early-access programs.
Is Applied Cells a public or private company?
Applied Cells is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Applied Cells founded?
Applied Cells was founded in 2016. It employs 11 to 50 people.
Where is Applied Cells based?
Applied Cells is headquartered in Santa Clara, United States, in the North America region.
How does Applied Cells make money?
Four revenue lines are on record. MARS Instruments are the primary driver. The others are reagent Kits, consumables and goFast CAR-T Kit.
Does Applied Cells have an API?
No public API is recorded for Applied Cells.
What industry is Applied Cells in?
Applied Cells's product category is Cell Separation and Cell Therapy Manufacturing Instruments. Its primary akta.pro industry code is HLAAABAG, Cell Therapy Manufacturing Platforms & Automation (closed systems, bioreactors, fill-finish), with a secondary code of HLAAABAH, Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables). Its NAICS code is 33451 and its SIC code is 3841.